Additional file 1 of A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

Ghesquières, Hervé; Rossi, Cédric; Cherblanc, Fanny; Le Guyader-Peyrou, Sandra; Bijou, Fontanet; Sujobert, Pierre; Fabbro-Peray, Pascale; Bernier, Adeline; Belot, Aurélien; Chartier, Loic; Fornecker, Luc-Matthieu; Baldi, Isabelle; Bouabdallah, Krimo; Laurent, Camille; Oberic, Lucie; Morineau, Nadine; Le Gouill, Steven; Morschhauser, Franck; Haioun, Corinne; Damaj, Gandhi; Guidez, Stéphanie; Labouré, Gaëlle; Fitoussi, Olivier; Lebras, Laure; Gressin, Rémy; Salles, Gilles; Ysebaert, Loïc; Monnereau, Alain

doi:10.6084/m9.figshare.14150948.v1

12889_2021_10433_MOESM1_ESM.docx (14.12 kB)

Additional file 1 of A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

journal contribution

posted on 2021-03-03, 04:34 authored by Hervé Ghesquières, Cédric Rossi, Fanny Cherblanc, Sandra Le Guyader-Peyrou, Fontanet Bijou, Pierre Sujobert, Pascale Fabbro-Peray, Adeline Bernier, Aurélien Belot, Loic Chartier, Luc-Matthieu Fornecker, Isabelle Baldi, Krimo Bouabdallah, Camille Laurent, Lucie Oberic, Nadine Morineau, Steven Le Gouill, Franck Morschhauser, Corinne Haioun, Gandhi Damaj, Stéphanie Guidez, Gaëlle Labouré, Olivier Fitoussi, Laure Lebras, Rémy Gressin, Gilles Salles, Loïc Ysebaert, Alain Monnereau

Additional file 1. Lymphoma subtypes included and excluded in the study, according to the 2016 WHO classification. Detailed list of lymphoma subtypes included and excluded of the study.

Funding

Roche Celgene International II SARL Takeda France SAS Janssen-Cilag Amgen SAS

History

Usage metrics

Keywords

Cohort study Outcomes Lymphoma patients Real life France

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

Funding

Roche Celgene International II SARL Takeda France SAS Janssen-Cilag Amgen SAS

History

Usage metrics

Categories

Keywords

Licence

Exports